Centogene announces nomination of jonathan sheldon to supervisory board

Cambridge, mass. and rostock, germany and berlin, nov. 13, 2020 (globe newswire) -- centogene (nasdaq: cntg), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced the nomination of dr. jonathan g. sheldon as a member of the supervisory board, which will be proposed to the shareholders at an upcoming extraordinary general meeting (egm). dr. sheldon will also serve with immediate effect as a member ad interim of the company's supervisory board.
CNTG Ratings Summary
CNTG Quant Ranking